Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2005 09:22 ET | Source: Crucell N.V.

Crucell Files Financial Statements with Euronext for H1 2005 in Accordance with IFRS

LEIDEN, Netherlands, Sept. 30, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has filed its Condensed Interim Financial Statements...
September 27, 2005 10:10 ET | Source: Crucell N.V.

Crucell Clarifies CFO Comment Made at UBS Conference

LEIDEN, Netherlands, Sept. 27, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) wishes to clarify a comment made by its Chief Financial Officer Leonard...
September 21, 2005 08:08 ET | Source: Crucell N.V.

Crucell to Present at UBS Global Life Sciences Conference, New York, September 26

LEIDEN, Netherlands, Sept. 21, 2005 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced that its Chief Financial Officer, Leonard Kruimer, will present at the UBS Global Life...
September 20, 2005 02:06 ET | Source: Crucell N.V.

Crucell Appoints Agents to Boost Asian Market Potential

LEIDEN, Netherlands, Sept. 20, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has entered into agreements with Pharma&Soft in...
September 16, 2005 02:11 ET | Source: Crucell N.V.

Crucell Secures 2 Million Grant from Dutch Ministry of Economic Affairs to Discover Antibodies Against Antibiotic-Resistant Bacterial Infections

LEIDEN, Netherlands, Sept. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has received a grant of up to 2 Million from the...
September 08, 2005 04:37 ET | Source: Crucell N.V.

Crucell and Aeras Announce Progress in TB Vaccine Program

LEIDEN, Netherlands, Sept. 8, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and Aeras Global TB Vaccine Foundation today announced the initiation of a...
August 17, 2005 02:15 ET | Source: Crucell N.V.

Crucell and US Navy Sign Agreement to Test AdVac-based Vaccine Against Anthrax and Plague

LEIDEN, Netherlands, Aug. 17, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a Cooperative Research and Development...
August 16, 2005 05:11 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6 Licensing Agreement with Chiron

LEIDEN, Netherlands, Aug. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have...
August 01, 2005 02:11 ET | Source: Crucell N.V.

Harvard and Crucell Receive $19.2 million NIH Grant to Develop Next-Generation AdVac-based Vaccines

LEIDEN, Netherlands, Aug. 1, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that it has, in collaboration with Harvard Medical School,...
July 18, 2005 09:34 ET | Source: Crucell N.V.

Crucell Announces Second Quarter 2005 Results

-- Increased development activity drives 34% growth in revenues for first half-year. -- New West Nile virus antibody discovered. -- May 10th capital raising provides funds for further...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right